At a Glance
| Mirtazapine | SAMe | |
|---|---|---|
| Class | Deliriant, Depressant, Antidepressants | Antidepressant, Nootropic |
| Common Dose (oral) | 130–190 mg | 400–800 mg |
| Total Duration | 1.9–3.9 hrs | 3.8–11 hrs |
| Routes | oral | Oral |
Dangerous Combination
Combining Mirtazapine and SAMe is classified as dangerous. Combined CNS depression; risk of respiratory failure
Mirtazapine, a Deliriant, Depressant, Antidepressants, and SAMe, a Antidepressant, Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Mirtazapine is classified as a Deliriant, Depressant, Antidepressants while SAMe is a Antidepressant, Nootropic, meaning they approach altered states through different pharmacological mechanisms. They share 9 documented effects in common, with 43 effects unique to Mirtazapine and 18 unique to SAMe. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Mirtazapine | SAMe | |
|---|---|---|
| Class | Deliriant, Depressant, Antidepressants | Antidepressant, Nootropic |
| Common Dose (oral) | 130–190 mg | 400–800 mg |
| Total Duration | 1.9–3.9 hrs | 3.8–11 hrs |
| Routes | oral | Oral |
| Effects | 52 documented | 27 documented |
| Interaction | Dangerous | |
| Level | Mirtazapine | SAMe |
|---|---|---|
| Threshold | 3.5 mg | 120 mg |
| Light | 70–130 mg | 200–400 mg |
| Common | 130–190 mg | 400–800 mg |
| Strong | 190–250 mg | 800–1200 mg |
| Heavy | 250 mg | 1600 mg |
Mirtazapine
SAMe
Combined CNS depression; risk of respiratory failure